3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
4
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Hairy Cell
2
Hematologic Neoplasms
2
Glioma
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lymphatic Metastasis
1
Klatskin Tumor
1
Interventions
Magnetic Resonance Spectroscopy
3
Steroids
2
Specimen Handling
2
Hormones
2
Cyclin-Dependent Kinase Inhibitor p18
2
Cyclin-Dependent Kinase Inhibitor p16
2
Biopsy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
abemaciclib
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
High-Energy Shock Waves
1
Capecitabine
1
CT-P6
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
binimetinib
×
90 days
×
Clear all
No trials found.